From: The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma
Characteristics | OS | Â | RFS | Â |
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Overall ovarian carcinomasa | Â | Â | Â | Â |
Age, y, ≥ 60 (vs < 60) | 2.100 (1.191-3.702) | 0.010 |  |  |
Stage, III & IV (vs I & II) | 2.488 (1.295-4.780) | 0.006 | 3.426 (1.944-6.036) | <0.001 |
Histologic grade, high (vs low) | Â | Â | 3.023 (1.355-6.742) | 0.007 |
DBC1, positive (vs negative) | 2.423 (1.144-5.132) | 0.021 | Â | Â |
Serous carcinomasb | Â | Â | Â | Â |
Age, y, ≥ 60 (vs < 60) | 2.241 (1.212-4.144) | 0.010 |  |  |
Stage, III & IV (vs I & II) | Â | Â | 3.023 (1.588-5.755) | <0.001 |
Histologic grade, high (vs low) | Â | Â | 4.818 (1.487-15.614) | 0.009 |
DBC1, positive (vs negative) | 3.757 (1.462-9.653) | 0.006 | Â | Â |
High-grade serous carcinomasc | Â | Â | Â | Â |
Age, y, ≥ 60 (vs < 60) | 1.961 (1.050-3.664) | 0.035 |  |  |
Stage, III & IV (vs I & II) | Â | Â | 2.488 (1.280-4.836) | 0.007 |
DBC1, positive (vs negative) | 3.828 (1.353-10.827) | 0.011 | 2.059 (0.907-4.677) | 0.084 |